InvestorsHub Logo
Followers 85
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: skweze post# 160657

Tuesday, 02/11/2014 1:29:03 PM

Tuesday, February 11, 2014 1:29:03 PM

Post# of 346455
dilution... ? I still think when we're talking about the potential that what lies ahead in the Bavi pipeline.

Institutionals/Funds/and more big boy types will be screaming that they want more dilution. If not... they'll be crying as they pay prices per share never seen before.

just my opinion from the basic belief that Bavituximab will be everywhere and as Krakonos says, will be serving Billions upon Billions. McDonalds will be jealous

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News